<TABLE> <S> <C>


<ARTICLE>                     5
<CIK>                         0001017157
<NAME>                        Genetic Vectors, Inc.

<S>                             <C>

<PERIOD-TYPE>                        9-MOS
<FISCAL-YEAR-END>                    DEC-31-2000
<PERIOD-START>                       JAN-01-2000
<PERIOD-END>                         SEP-30-2000
<CASH>                               434,658
<SECURITIES>                         0
<RECEIVABLES>                        36,003
<ALLOWANCES>                         0
<INVENTORY>                          23,996
<CURRENT-ASSETS>                     523,638
<PP&E>                               805,989
<DEPRECIATION>                       (357,996)
<TOTAL-ASSETS>                       1,210,008
<CURRENT-LIABILITIES>                4,455,258
<BONDS>                              0
                0
                          0
<COMMON>                             3,738
<OTHER-SE>                           (3,248,988)
<TOTAL-LIABILITY-AND-EQUITY>         (1,210,008)
<SALES>                              96,132
<TOTAL-REVENUES>                     96,132
<CGS>                                25,293
<TOTAL-COSTS>                        2,423,823
<OTHER-EXPENSES>                     2,954,665
<LOSS-PROVISION>                     0
<INTEREST-EXPENSE>                   276,577
<INCOME-PRETAX>                      (5,282,356)
<INCOME-TAX>                         0
<INCOME-CONTINUING>                  (5,282,356)
<DISCONTINUED>                       0
<EXTRAORDINARY>                      0
<CHANGES>                            0
<NET-INCOME>                         (5,282,356)
<EPS-BASIC>                          (1.45)
<EPS-DILUTED>                        (1.45)


</TABLE>



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission